Obstacles and advances in SARS vaccine development.
Identifieur interne : 001183 ( Ncbi/Curation ); précédent : 001182; suivant : 001184Obstacles and advances in SARS vaccine development.
Auteurs : Deborah R. Taylor [États-Unis]Source :
- Vaccine [ 0264-410X ] ; 2006.
Descripteurs français
- KwdFr :
- MESH :
- génétique : Virus du SRAS.
- immunologie : Vaccins antiviraux, Vaccins synthétiques, Vaccins à ADN, Virion, Virus du SRAS.
- sang : Anticorps antiviraux.
- Animaux, Humains, Modèles animaux de maladie humaine.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Antibodies, Viral.
- genetics : SARS Virus.
- immunology : SARS Virus, Vaccines, DNA, Vaccines, Synthetic, Viral Vaccines, Virion.
- Animals, Disease Models, Animal, Humans.
Abstract
The emergence of the severe acute respiratory syndrome (SARS) that resulted in a pandemic in 2003 spurred a flurry of interest in the development of vaccines to prevent and treat the potentially deadly viral infection. Researchers around the world pooled their scientific resources and shared early data in an unprecedented manner in light of the impending public health crisis. There are still large gaps in knowledge about the pathogenesis of this virus. While significant advances have been made in the development of animal models, the practicality of their use may be hampered by a lack of pathological similarity with human disease. Described here are issues related to progress in vaccine development and the obstacles that lie ahead for both researchers and regulatory agencies.
DOI: 10.1016/j.vaccine.2005.08.102
PubMed: 16191455
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002521
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002521
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002082
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001183
Links to Exploration step
pubmed:16191455Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Obstacles and advances in SARS vaccine development.</title>
<author><name sortKey="Taylor, Deborah R" sort="Taylor, Deborah R" uniqKey="Taylor D" first="Deborah R" last="Taylor">Deborah R. Taylor</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Bethesda, MD 20892, USA. taylord@cber.fda.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Bethesda, MD 20892</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16191455</idno>
<idno type="pmid">16191455</idno>
<idno type="doi">10.1016/j.vaccine.2005.08.102</idno>
<idno type="wicri:Area/PubMed/Corpus">002521</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002521</idno>
<idno type="wicri:Area/PubMed/Curation">002521</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002521</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002082</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002082</idno>
<idno type="wicri:Area/Ncbi/Merge">001183</idno>
<idno type="wicri:Area/Ncbi/Curation">001183</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Obstacles and advances in SARS vaccine development.</title>
<author><name sortKey="Taylor, Deborah R" sort="Taylor, Deborah R" uniqKey="Taylor D" first="Deborah R" last="Taylor">Deborah R. Taylor</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Bethesda, MD 20892, USA. taylord@cber.fda.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Bethesda, MD 20892</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies, Viral (blood)</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (immunology)</term>
<term>Vaccines, DNA (immunology)</term>
<term>Vaccines, Synthetic (immunology)</term>
<term>Viral Vaccines (immunology)</term>
<term>Virion (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Anticorps antiviraux (sang)</term>
<term>Humains</term>
<term>Modèles animaux de maladie humaine</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Vaccins synthétiques (immunologie)</term>
<term>Vaccins à ADN (immunologie)</term>
<term>Virion (immunologie)</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antiviraux</term>
<term>Vaccins synthétiques</term>
<term>Vaccins à ADN</term>
<term>Virion</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
<term>Vaccines, DNA</term>
<term>Vaccines, Synthetic</term>
<term>Viral Vaccines</term>
<term>Virion</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Humains</term>
<term>Modèles animaux de maladie humaine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The emergence of the severe acute respiratory syndrome (SARS) that resulted in a pandemic in 2003 spurred a flurry of interest in the development of vaccines to prevent and treat the potentially deadly viral infection. Researchers around the world pooled their scientific resources and shared early data in an unprecedented manner in light of the impending public health crisis. There are still large gaps in knowledge about the pathogenesis of this virus. While significant advances have been made in the development of animal models, the practicality of their use may be hampered by a lack of pathological similarity with human disease. Described here are issues related to progress in vaccine development and the obstacles that lie ahead for both researchers and regulatory agencies.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001183 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001183 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:16191455 |texte= Obstacles and advances in SARS vaccine development. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:16191455" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |